Search | Page 36 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... This is a Phase 2, open-label, randomized, controlled clinical study of pediatric subjects treated with pamidronate with calcium and ...

    Clinical Trial last updated 04/27/2016 - 3:48pm.

  2. Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... to assess the safety, tolerability, and preliminary clinical effects of BVD-523 given orally, twice daily for 21-day cycles, in ...

    Clinical Trial last updated 04/27/2016 - 3:39pm.

  3. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... stage the selected dose will be confirmed and evaluated for clinical activity, including response rate. ...

    Clinical Trial last updated 04/27/2016 - 2:05pm.

  4. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) infusion, in ...

    Clinical Trial last updated 04/27/2016 - 1:31pm.

  5. A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... dysplasia, and Chronic Myelomonocytic Leukemia (CMML). This clinical study includes two components: (a) a Phase 1b safety lead in and (b) a ...

    Clinical Trial last updated 04/27/2016 - 1:20pm.

  6. An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:49am.

  7. An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:47am.

  8. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  9. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  10. Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:31am.